Aspire Health Partners

Aspire Health Partners (Orlando, FL) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility offers specific levels of care: Inpatient, MAT. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Aspire Health Partners

Level-of-care documentation: The facility's documented care levels are The facility offers specific levels of care: Inpatient, MAT. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

Aspire Health Partners accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Pre-admission due-diligence for Aspire Health Partners: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via FL behavioral-health regulator inspection records. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.